Covishield Covid Vaccine
-
{
- All
- News
- Videos
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Drug Regulator Seeks More Data Over Approval For Covishield Booster: Report
An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
-
Blog: One Covid Shot Is No Protection, Cut The Gap For The Second
Vaccination and curbs are not going to stop breakthrough cases as no vaccine is 100% effective, but almost all of them, when fully vaccinated, provide very high levels of protection from severe illness and death.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
-
Centre Buys 1.1 Crore Covishield Doses, Another 4.5 Crore By April
The government plans to purchase a total of 5.60 crore doses of Serum Institute of India's Covishield vaccine by April 2021, at Rs 200 per dose. While 1.10 crore doses of Covishield were purchased on Monday, there is a "commitment" to purchase another 4.50 crore doses by April 2021.
-
Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Drug Regulator Seeks More Data Over Approval For Covishield Booster: Report
An expert panel of India's central drug authority reviewed Serum Institute's application for approval of Covishield as booster dose against COVID-19 on Friday.
-
Blog: One Covid Shot Is No Protection, Cut The Gap For The Second
Vaccination and curbs are not going to stop breakthrough cases as no vaccine is 100% effective, but almost all of them, when fully vaccinated, provide very high levels of protection from severe illness and death.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
-
Centre Buys 1.1 Crore Covishield Doses, Another 4.5 Crore By April
The government plans to purchase a total of 5.60 crore doses of Serum Institute of India's Covishield vaccine by April 2021, at Rs 200 per dose. While 1.10 crore doses of Covishield were purchased on Monday, there is a "commitment" to purchase another 4.50 crore doses by April 2021.
